Consolidated Income Statements (USD $) In Thousands, except Per Share data	12 Months Ended
	Oct. 02, 2011	Oct. 03, 2010	Sep. 27, 2009
Net Sales	$ 835,854	$ 518,268	$ 452,972
Cost of sales	394,683	270,057	272,565
Gross profit	441,171	248,211	180,407
Operating expenses:
Selling, general and administrative	187,529	114,663	113,080
Research and development costs	114,155	55,395	41,435
In-process research & development			1,310
Amortization of intangible assets	62,425	20,165	15,203
Restructuring and severance charges	22,081	2,107	13,264
Impairment charges related to facility closures			6,185
Total operating expenses	386,190	192,330	190,477
Operating income (loss)	54,981	55,881	(10,070)
Other income (expenses):
Interest expense	(16,654)	(756)	(352)
Interest income	383	432	1,221
Other, net	(16,661)	(526)	327
Total other income (loss)	(32,932)	(850)	1,196
Income (loss) before income taxes	22,049	55,031	(8,874)
Provision (benefit) for income taxes	(32,398)	(4,007)	17,949
Net income (loss)	$ 54,447	$ 59,038	$ (26,823)
Earnings (loss) per share:
Basic	$ 0.65	$ 0.73	$ (0.33)
Diluted	$ 0.63	$ 0.72	$ (0.33)
Weighted-average common shares outstanding:
Basic	83,916	80,797	80,943
Diluted	85,747	81,541	80,943